[1]胡思芹,李运新,曾福英.血清AFP、CEA、CA199、CA724联合检测对消化道恶性肿瘤的诊断价值[J].医学信息,2020,33(15):170-171176.[doi:10.3969/j.issn.1006-1959.2020.15.054]
　HU Si-qin,LI Yun-xin,ZENG Fu-ying.The Diagnostic Value of Combined Detection of Serum AFP,CEA,CA199,CA724 for Malignant Tumors of Digestive Tract[J].Medical Information,2020,33(15):170-171176.[doi:10.3969/j.issn.1006-1959.2020.15.054]
点击复制

血清AFP、CEA、CA199、CA724联合检测对消化道恶性肿瘤的诊断价值()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年15期
页码:
170-171176
栏目:
诊疗技术
出版日期:
2020-08-01

文章信息/Info

Title:
The Diagnostic Value of Combined Detection of Serum AFP,CEA,CA199,CA724 for Malignant Tumors of Digestive Tract
文章编号:
1006-1959（2020）15-0170-03
作者:
胡思芹; 李运新; 曾福英
五华县中医医院检验科，广东 梅州 514000
Author(s):
HU Si-qin; LI Yun-xin; ZENG Fu-ying
Department of Laboratory Medicine,Wuhua County Traditional Chinese Medicine Hospital,Meizhou 514000,Guangdong,China
关键词:
恶性肿瘤; 甲胎蛋白; 癌胚抗原; 糖类抗原199; 胃癌抗原
Keywords:
Malignant tumor; Alpha-fetoprotein; Carcinoembryonic antigen; Carbohydrate antigen 199; Gastric cancer antigen
分类号:
R735
DOI:
10.3969/j.issn.1006-1959.2020.15.054
文献标志码:
A
摘要:
目的 探究血清AFP、CEA、CA199、CA724联合检测对消化道恶性肿瘤的诊断价值。方法 选取2017年1月~2019年1月我院收治的消化道恶性肿瘤患者160例设为研究组，其中肝癌35例，胰腺癌42例，胃癌37例，大肠癌46例；另选取同期健康体检者45名设为参照组；比较两组血清AFP、CEA、CA199、CA724水平，分析血清AFP、CEA、CA199、CA724单独检测及联合检测不同消化道恶性肿瘤的阳性率、灵敏度及特异度。结果 研究组中肝癌、胰腺癌、胃癌、大肠癌血清AFP、CEA、CA199、CA724水平高于参照组，差异有统计学意义（P＜0.05）；AFP+CEA+CA199+CA724联合检测肝癌、胰腺癌、胃癌及大肠癌的阳性率、灵敏度及特异度高于任一项单独检测值，差异有统计学意义（P＜0.05）。结论 血清AFP、CEA、CA联合检测可作为判断消化道恶性肿瘤的重要指标，且联合检测可提高诊断的阳性率、灵敏度及特异度。
Abstract:
Objective To explore the diagnostic value of combined detection of serum AFP, CEA, CA199 and CA724 for malignant tumors of the digestive tract. Methods A total of 160 patients with gastrointestinal malignancies admitted to our hospital from January 2017 to January 2019 were selected as the study group, including 35 liver cancers, 42 pancreatic cancers, 37 gastric cancers, and 46 colorectal cancers; the other healthy patients in the same period were selected. 45 physical examination subjects were set as the reference group; the serum levels of AFP, CEA, CA199, and CA724 were compared between the two groups, and the positive rate, sensitivity, and specificity of serum AFP, CEA, CA199, and CA724 were analyzed separately and combined with different gastrointestinal malignancies.Results The serum levels of AFP, CEA, CA199, and CA724 in liver cancers, pancreatic cancers, gastric cancers, and colorectal cancers of the study group were higher than those in the reference group, the difference was statistically significant (P＜0.05); the positive rate and sensitivity of AFP+CEA+CA199+CA724 combined detection of liver cancer, pancreatic cancer, gastric cancer and colorectal cancer and the specificity was higher than any of the individual detection values, the difference was statistically significant (P<0.05).Conclusion The combined detection of serum AFP, CEA, and CA can be used as an important indicator for judging malignant tumors of the digestive tract, and the combined detection can improve the positive rate, sensitivity and specificity of diagnosis.

参考文献/References:

[1]李争,李强,肖强,等.甲胎蛋白、癌胚抗原和糖链抗原19-9联合检测诊断消化系统恶性肿瘤的价值分析[J].癌症进展,2017,15(4):432-434.[2]王敏,孙亮.TK1、CEA、CA199检测在结肠癌诊断中的应用价值[J].南京医科大学学报：自然科学版,2017,37(9):1182-1184.[3]王梅,孟华,刘晓颖.AFP、CEA、CA199、CA724联合检测在消化道恶性肿瘤中的临床价值[J].胃肠病学和肝病学杂志,2017,20(6): 546-548.[4]向焰,龙天蓉,陈亮.肿瘤标志物CA199、CA242及CA50联合检测对胰腺癌早期诊断的价值[J].检验医学与临床,2017,14(2):137-138.[5]邹珍珍,王坤,何璐,等.异常凝血酶原和甲胎蛋白联合检测在原发性肝癌中的临床价值[J].检验医学与临床,2019,16(12):1771-1773.[6]贺靳贤,陈琪峰,等.食管癌患者血清中多项肿瘤标志物测定的临床意义[J].中国卫生检验杂志,2018,28(12):1490-1492.[7]顾万娟,杜希林.IL-6、TSGF联合肿瘤标记物CEA、CA724检测在胃癌中的诊断价值[J].检验医学与临床,2019,16(12):1709-1711.[8]贺靳贤,陈琪峰,陈彪.食管癌患者血清中多项肿瘤标志物测定的临床意义[J].中国卫生检验杂志,2018,28(12):1490-1492.[9]韩克松,李翠玲,李阳,等.胃癌患者应用CA724、CEA、CA242、CA199肿瘤标志物联合检验的临床价值[J].现代消化及介入诊疗,2017,22(6):811-813.[10]汪桂霞.胃癌行CA724、CEA、CA242、CA199肿瘤标志物联合检测的价值[J].现代中西医结合杂志,2015,24(4):430-431.

相似文献/References:

[1]袁东方,张刚刚.恶性肿瘤病历主要诊断选择思路分析[J].医学信息,2018,31(07):28.[doi:10.3969/j.issn.1006-1959.2018.07.010]
　YUAN Dong-fang,ZHANG Gang-gang.Analysis of Main Diagnostic Options for Malignant Tumor Records[J].Medical Information,2018,31(15):28.[doi:10.3969/j.issn.1006-1959.2018.07.010]
[2]杨 洋,李秀惠.HBV 相关慢加急（亚急）性肝衰竭患者血清AFP、CA199临床意义的研究[J].医学信息,2019,32(09):61.[doi:10.3969/j.issn.1006-1959.2019.09.020]
　YANG Yang,LI Xiu-hui.Clinical Significance of Serum AFP and CA199 in Patients with HBV-related Slow-acceleration (Sub-acute) Liver Failure[J].Medical Information,2019,32(15):61.[doi:10.3969/j.issn.1006-1959.2019.09.020]
[3]何 静.上皮性卵巢癌化学治疗的研究[J].医学信息,2019,32(18):24.[doi:10.3969/j.issn.1006-1959.2019.18.009]
　HE Jing.Chemotherapy of Epithelial Ovarian Cancer[J].Medical Information,2019,32(15):24.[doi:10.3969/j.issn.1006-1959.2019.18.009]
[4]梁春玲,杨文珊.消化道恶性肿瘤的临床分析[J].医学信息,2019,32(18):124.[doi:10.3969/j.issn.1006-1959.2019.18.041]
　LIANG Chun-ling,YANG Wen-shan.Clinical Analysis of Malignant Tumors of the Digestive Tract[J].Medical Information,2019,32(15):124.[doi:10.3969/j.issn.1006-1959.2019.18.041]
[5]陈云娥,李 璠,张子怡,等.营养支持治疗对终末期恶性肿瘤患者临床结局影响的Meta分析[J].医学信息,2019,32(19):63.[doi:10.3969/j.issn.1006-1959.2019.19.019]
　CHEN Yun-e,LI Fan,ZHANG Zi-yi,et al.Meta-analysis of Effect of Nutritional Support Therapy on Clinical Outcome of Patients with Terminal-stage Malignant Tumor[J].Medical Information,2019,32(15):63.[doi:10.3969/j.issn.1006-1959.2019.19.019]
[6]杜鑫荣.超声造影在肝实质性肿块诊断及鉴别中的临床价值[J].医学信息,2019,32(19):176.[doi:10.3969/j.issn.1006-1959.2019.19.059]
　DU Xin-rong.Clinical Value of Contrast-enhanced Ultrasonography in the Diagnosis and Differential Diagnosis of Liver Mass[J].Medical Information,2019,32(15):176.[doi:10.3969/j.issn.1006-1959.2019.19.059]
[7]姜天奇,张洪亮.原发性肝癌的中西医治疗现状[J].医学信息,2019,32(13):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
　JIANG Tian-qi,ZHANG Hong-liang.Current Status of Treatment of Primary Liver Cancer with Traditional Chinese Medicine and Western Medicine[J].Medical Information,2019,32(15):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
[8]易亭伍,邓窈窕,宿向东.恶性肿瘤患者及家属信息需求现状的多中心研究[J].医学信息,2019,32(22):72.[doi:10.3969/j.issn.1006-1959.2019.22.023]
　YI Ting-wu,DENG Yao-tiao,SU Xiang-dong.Multi-center Study on the Status of Information Needs of Patients with Malignant Tumors and their Families[J].Medical Information,2019,32(15):72.[doi:10.3969/j.issn.1006-1959.2019.22.023]
[9]赵博志,赵国林,杨 敏,等.乳腺鳞状细胞癌的临床诊疗研究[J].医学信息,2020,33(03):46.[doi:10.3969/j.issn.1006-1959.2020.03.014]
　ZHAO Bo-zhi,ZHAO Guo-lin,YANG Min,et al.Clinical Diagnosis and Treatment of Squamous Cell Carcinoma of the Breast[J].Medical Information,2020,33(15):46.[doi:10.3969/j.issn.1006-1959.2020.03.014]
[10]吴鑫阳,方明治.中医药治疗恶性肿瘤相关性贫血现状[J].医学信息,2020,33(06):31.[doi:10.3969/j.issn.1006-1959.2020.06.010]
　ZHANG Zhe.Status of Treatment of Malignant Tumor-related Anemia with Traditional Chinese Medicine[J].Medical Information,2020,33(15):31.[doi:10.3969/j.issn.1006-1959.2020.06.010]

更新日期/Last Update: 1900-01-01